Advanced Recurrent Hepatocellular Carcinoma: Treatment with Sorafenib Alone or in Combination with Transarterial Chemoembolization and Radiofrequency Ablation

Zhenwei Peng(Peking University), Ming Kuang(Sun Yat-sen University), Jiaping Li(Sun Yat-sen University), Mengchao Wei(Chinese Academy of Medical Sciences & Peking Union Medical College), Bin Li(Sun Yat-sen University), Yu Wang(Sun Yat-sen University), Xiaoyan Xie(Sun Yat-sen University), Chunlin Jiang(The First Affiliated Hospital, Sun Yat-sen University), Shuling Chen(Jiangsu University of Science and Technology), Minshan Chen(Sun Yat-sen University), Jie Mei(Sun Yat-sen University), Guojun Qian(Shanghai Jiao Tong University), Manxia Lin(Sun Yat-sen University)
Radiology
February 1, 2018
10.1148/radiol.2018171541
Cited by 74

Related Papers

Global patterns of hepatocellular carcinoma management from diagnosis to death: the <scp>BRIDGE</scp> Study
|Liver International|2015|1.3k
The prognostic significance of the prognostic nutritional index in cancer: a systematic review and meta-analysis
|Journal of Cancer Research and Clinical Oncology|2014|414
Ultrasound-based radiomics score: a potential biomarker for the prediction of microvascular invasion in hepatocellular carcinoma
|European Radiology|2018|201
Preoperative prediction of microvascular invasion in hepatocellular cancer: a radiomics model using Gd-EOB-DTPA-enhanced MRI
|European Radiology|2019|197
CT-based peritumoral radiomics signatures to predict early recurrence in hepatocellular carcinoma after curative tumor resection or ablation
|Cancer Imaging|2019|185